Baxter (BAX) Reports In-Line Q2 EPS
Get Alerts BAX Hot Sheet
Price: $23.90 -0.29%
Revenue Growth %: +2.5%
Financial Fact:
Net sales: 2.56B
Today's EPS Names:
PKE, BYRN, HELE, More
Revenue Growth %: +2.5%
Financial Fact:
Net sales: 2.56B
Today's EPS Names:
PKE, BYRN, HELE, More
Join SI Premium – FREE
Baxter (NYSE: BAX) reported Q2 EPS of $0.87, in-line with the analyst estimate of $0.87. Revenue for the quarter came in at $3.75 billion versus the consensus estimate of $3.88 billion.
GUIDANCE:
Baxter sees FY2022 EPS of $3.60-$3.70, versus the consensus of $4.13.
For earnings history and earnings-related data on Baxter (BAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Humana soars, Alignment Healthcare on Medicare rating changes
- AngioDynamics (ANGO) Tops Q1 EPS by 7c, Beats on Revenue; Offers F27 Revenue Guidance
- Potential Starbucks-Chipotle merger: major opportunity or expensive distraction?
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share